The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS.
The UC-based California HIV/AIDS Research Program (CHRP) has awarded grants totaling $11.8 million to see if a current HIV drug can be used to prevent the onset of the virus.
A San Francisco physician who oversaw the city’s efforts to prevent HIV infections has been named as director of the Office of National AIDS Policy.
The AIDS Quilt returns to San Francisco this weekend for the first time in a decade. Several dozen panels will be on display Sunday at several locations in the Castro District.
Kaiser is considered the national model because its HIV mortality rates are half the average across the country, and because the program has enrolled – and kept – people in its programs at a rate of 90%, more than double the rest of the country.
The city of San Francisco has found enough money to maintain $1.8 million in HIV/AIDS services that were jeopardized by federal funding cuts.
A San Francisco stem cell research facility is looking to replicate a trial where a man had HIV successfully removed from his system.
Sunday’s AIDS Walk San Francisco raised more than $3 million and has raised more than $77 million since it started in 1987.
An interview with Dr. Mervyn Silverman on the AIDS epidemic, 30 years after the first cases were reported in the United States.
Asian and Pacific Islander women had the highest rate of increase for HIV infection in the U.S., that according to the Centers for Disease Control and Prevention.